InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by MURDOCK TERRY L, Chief Operating Officer. Insider active across 1 companies, notably G1 Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
012,000 shares0
Common Stock
SEC:0001562180-22-000307·
012,000 shares0
Common Stock
SEC:0001562180-22-000307:0·
2 of 2 declarations
About MURDOCK TERRY L
Terry L. Murdock is the Chief Operating Officer at G1 Therapeutics, Inc. He is responsible for managing operations and organizational efficiency. G1 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments.
